SCHEMBL7654361

SCHEMBL7654361

O=S(=O)(Cl)c1ccc(Oc2ccc(-c3ncc[nH]3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP19A1 P11511 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
NISCH Q9Y2I1 2/20 0.47
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 3/20 0.47
MTOR P42345 1/20 0.46
ADK P55263 1/20 0.46
PDE3B Q13370 1/20 0.42
PDE3A Q14432 1/20 0.42
KCNH2 Q12809 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
CHEK2 O96017 4/20 0.40
HTT P42858 1/20 0.37
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6198745 0.89 NISCH (0.55) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
Hydrochloric Acid SCHEMBL7654365 0.85 ALDH1A1 (0.48) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL5151126 0.79 NISCH (0.69) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL22530455 0.78 CYP3A4 (0.55) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL1386454 0.78 CYP1A2 (0.55) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL7313533 0.76 CYP1A2 (0.54) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL9720036 0.76 HTT (0.58) ALDH1A1HTTLMNA
SCHEMBL433497 0.76 HTT (0.58) ALDH1A1HTTLMNA
SCHEMBL1288593 0.76 NISCH (0.59) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL10425373 0.76 ALDH1A1 (0.57) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6339092-B1 FOR THERAPY RHEUMATOID ARTHRITIS, ARTHROSIS, TUMOUR INVASION AND GROWTH, INCLUDING MALIGNANT SPREAD AND THE FORMATION OF METASTASES, ULCERATIONS, ATHEROSCLEROSIS ADIR ET COMPAGNIE (FR) 2002-01-15 US disclosed